Melinda Lackey Steps Down as General Counsel and Senior Vice President of Legal Affairs of Valion Bio

Melinda Lackey left the role of General Counsel and Senior Vice President of Legal Affairs at Valion Bio on October 30, 2026, according to an SEC filing.

Valion Bio disclosed in a filing made November 2, 2026 that it notified Melinda Lackey, its General Counsel and Senior Vice President of Legal Affairs, on October 27 that her employment would end, effective October 30, 2026. The company and Lackey then entered into a separation agreement and general release on October 31. (Source: an SEC filing.)

More legal leadership moves at Valion Bio

• Melinda Lackey Named General Counsel and Senior Vice President of Legal Affairs of Valion Bio (May 4, 2026)

Other general counsel moves in October 2026

• Arthi Chakravarthy Steps Down as Chief Legal Officer and Corporate Secretary of Enovix (October 30, 2026)
• Javier Rodriguez Steps Down as Senior Vice President, Chief Legal Officer and Corporate Secretary of BioXcel Therapeutics (October 30, 2026)
• Heather Novitsky Steps Down as General Counsel of LendingTree (October 30, 2026)
• Mitchell Brie Named Chief Compliance Officer of CareCloud (October 27, 2026)
• Ignacio Walker Named Chief Legal Officer of Bunge Global (October 5, 2026)
• Edward Traynor Named Interim Chief Legal Officer of Flutter Entertainment (October 1, 2026)
• Tom Whittaker Steps Down as Chief Legal Officer of JE Dunn Construction (October 29, 2026)
• Colby Cox Named Chief Legal Officer of JE Dunn Construction (October 29, 2026)

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.